Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Invested Capital (2021 - 2025)

Cytek Biosciences (CTKB) has disclosed Return on Invested Capital for 5 consecutive years, with 0.25% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 19.0% year-over-year to 0.25%, compared with a TTM value of 0.25% through Dec 2025, down 19.0%, and an annual FY2025 reading of 0.24%, down 19.0% over the prior year.
  • Return on Invested Capital was 0.25% for Q4 2025 at Cytek Biosciences, down from 0.07% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.01% in Q3 2021 and bottomed at 3.36% in Q2 2021.
  • Average Return on Invested Capital over 5 years is 0.22%, with a median of 0.05% recorded in 2024.
  • The sharpest move saw Return on Invested Capital skyrocketed 336bps in 2022, then fell -19bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.01% in 2021, then tumbled by -173bps to 0.01% in 2022, then tumbled by -528bps to 0.05% in 2023, then fell by -5bps to 0.06% in 2024, then crashed by -351bps to 0.25% in 2025.
  • Business Quant data shows Return on Invested Capital for CTKB at 0.25% in Q4 2025, 0.07% in Q3 2025, and 0.06% in Q2 2025.